Maximum quantity allowed is 999
Please select the quantity
CAS RN: 147098-20-2 | Product Number: R0180
Rosuvastatin Calcium
×
![]()
×
Purity: >95.0%(HPLC)(N)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 200MG |
$156.00
|
13 | 7 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | R0180 |
| Purity / Analysis Method | >95.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__4__4H__5__4CaF__2N__6O__1__2S__2 = 1,001.14 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container | 200MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 147098-20-2 |
| Related CAS RN | 287714-41-4 |
| Reaxys Registry Number | 7740139 |
| PubChem Substance ID | 253661249 |
| Merck Index (14) | 8270 |
| MDL Number | MFCD04112702 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(with Total Nitrogen) | min. 95.0 % |
| Purity(Chelometric Titration) | min. 90.0 % |
| Specific rotation [a]20/D | -7.0 to -10.0 deg(C=1, CHCL3) |
Properties (reference)
| Melting Point | 160 °C |
| Specific Rotation | -8° (C=1,CHCl3) |
| Maximum Absorption Wavelength | 243(Phosphate buffer sol.) nm |
GHS
Related Laws:
| RTECS# | MJ9675070 |
Transport Information:
| H.S.code* | 2935.90-000 |
Application
VSV-G lentivirus vector transduction enhancer
Rosuvastatin enhances VSV-G lentiviral transduction of NK Cells.1)
References
- 1) Rosuvastatin enhances VSV-G lentiviral transduction of NK cells via upregulation of the low-density lipoprotein receptor
Application
Rosuvastatin Calcium: A Strong HMG-Coa Reductase Inhibitor (a Strong Statin)
Rosuvastatin calcium is a 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor (statin). Compared with most other statins, rosuvastatin possesses a greater number of binding interactions with HMG-CoA reductase and exhibits greater potency in inhibiting enzyme activity and cholesterol synthesis in hepatic cells than other statins. Rosuvastatin is relatively hydrophilic, similar in this respect to pravastatin [P1796]. Rosuvastatin has one of the longest terminal half-life of the statins and is only minimally metabolized by the cytochrome P 450 (CYP 450) enzyme system with no significant involvement of the 3A4 (CYP3A4) enzyme.
References
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (a review)
- A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin
- Structural mechanism for statin inhibition of HMG-CoA reductase
- Determination of simvastatin, pravastatin sodium and rosuvastatin calcium in tablet dosage forms by HPTLC
- A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.